Literature DB >> 25898888

Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.

Tyler A Landrith1, Tajie H Harris, Emma H Wilson.   

Abstract

The rise of the AIDS epidemic made the requirement for T cells in our continuous protection from pathogens critically apparent. The striking frequency with which AIDS patients exhibited profound neurological pathologies brought attention to many chronic infections that are latent within the immune-privileged CNS. One of the most common lethal opportunistic infections of these patients was with the protozoan parasite, Toxoplasma gondii. Reactivation of Toxoplasma cysts within the brain causes massive tissue destruction evidenced as multiple ring-enhancing lesions on MRI and is called toxoplasmic encephalitis (TE). TE is not limited to AIDS patients, but rather is a risk for all severely immunocompromised patients, including recipients of chemotherapy or transplant recipients. The lessons learned from these patient populations are supported by T cell depletion studies in mice. Such experiments have demonstrated that CD4+ and CD8+ T cells are required for protection against TE. Although it is clear that these T cell subsets work synergistically to fight infection, much evidence has been generated that suggests CD8+ T cells play a dominant role in protection during chronic toxoplasmosis. In other models of CNS inflammation, such as intracerebral infection with LCMV and experimental autoimmune encephalomyelitis (EAE), infiltration of T cells into the brain is harmful and even fatal. In the brain of the immunocompetent host, the well-regulated T cell response to T. gondii is therefore an ideal model to understand a controlled inflammatory response to CNS infection. This review will examine our current understanding of CD8+ T cells in the CNS during T. gondii infection in regards to the (1) mechanisms governing entry into the brain, (2) cues that dictate behavior within the brain, and (3) the functional and phenotypic properties exhibited by these cells.

Entities:  

Mesh:

Year:  2015        PMID: 25898888      PMCID: PMC5313077          DOI: 10.1007/s00281-015-0487-3

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  77 in total

1.  T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.

Authors:  P Kivisäkk; C Trebst; Z Liu; B H Tucky; T L Sørensen; R A Rudick; M Mack; R M Ransohoff
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection.

Authors:  Corinne C Ploix; Shahani Noor; Janelle Crane; Kokoechat Masek; Whitney Carter; David D Lo; Emma H Wilson; Monica J Carson
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

3.  VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.

Authors:  Qila Sa; Eri Ochiai; Tomoko Sengoku; Melinda E Wilson; Morgan Brogli; Stephen Crutcher; Sara A Michie; Baohui Xu; Laura Payne; Xisheng Wang; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

4.  Importance of CD8(+)Vbeta8(+) T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice.

Authors:  Xisheng Wang; Jennifer Claflin; Hoil Kang; Yasuhiro Suzuki
Journal:  J Interferon Cytokine Res       Date:  2005-06       Impact factor: 2.607

5.  Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study.

Authors:  T C Melzer; H J Cranston; L M Weiss; S K Halonen
Journal:  J Neuroparasitology       Date:  2010

Review 6.  Lymphoid chemokines in the CNS.

Authors:  Stephen J Lalor; Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2010-06-01       Impact factor: 3.478

7.  PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.

Authors:  Karthik Sathiyanadan; Caroline Coisne; Gaby Enzmann; Urban Deutsch; Britta Engelhardt
Journal:  Eur J Immunol       Date:  2014-05-11       Impact factor: 5.532

8.  Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.

Authors:  Dionna W Williams; Tina M Calderon; Lillie Lopez; Loreto Carvallo-Torres; Peter J Gaskill; Eliseo A Eugenin; Susan Morgello; Joan W Berman
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

9.  Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.

Authors:  Tajie H Harris; Edward J Banigan; David A Christian; Christoph Konradt; Elia D Tait Wojno; Kazumi Norose; Emma H Wilson; Beena John; Wolfgang Weninger; Andrew D Luster; Andrea J Liu; Christopher A Hunter
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

10.  VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.

Authors:  Tilman Schneider-Hohendorf; Jan Rossaint; Hema Mohan; Daniel Böning; Johanna Breuer; Tanja Kuhlmann; Catharina C Gross; Ken Flanagan; Lydia Sorokin; Dietmar Vestweber; Alexander Zarbock; Nicholas Schwab; Heinz Wiendl
Journal:  J Exp Med       Date:  2014-08-18       Impact factor: 14.307

View more
  14 in total

Review 1.  Infectious immunity in the central nervous system and brain function.

Authors:  Robyn S Klein; Charise Garber; Nicole Howard
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 2.  Revisiting the Mechanisms of CNS Immune Privilege.

Authors:  Antoine Louveau; Tajie H Harris; Jonathan Kipnis
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

Review 3.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

4.  Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.

Authors:  Nahiara Esteves Zorgi; Andrés Jimenez Galisteo; Maria Notomi Sato; Nanci do Nascimento; Heitor Franco de Andrade
Journal:  Med Microbiol Immunol       Date:  2016-01-05       Impact factor: 3.402

5.  Transcriptomic and clonal characterization of T cells in the human central nervous system.

Authors:  Jenna L Pappalardo; Le Zhang; Maggie K Pecsok; Kelly Perlman; Chrysoula Zografou; Khadir Raddassi; Ahmad Abulaban; Smita Krishnaswamy; Jack Antel; David van Dijk; David A Hafler
Journal:  Sci Immunol       Date:  2020-09-18

Review 6.  Targeting the Brain Reservoirs: Toward an HIV Cure.

Authors:  Céline Marban; Faezeh Forouzanfar; Amina Ait-Ammar; Faiza Fahmi; Hala El Mekdad; Fadoua Daouad; Olivier Rohr; Christian Schwartz
Journal:  Front Immunol       Date:  2016-09-30       Impact factor: 7.561

Review 7.  The Roles of Mast Cells in Parasitic Protozoan Infections.

Authors:  Fangli Lu; Shiguang Huang
Journal:  Front Immunol       Date:  2017-04-06       Impact factor: 7.561

Review 8.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

9.  ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.

Authors:  Carleigh A O'Brien; Tajie H Harris
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

Review 10.  Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection.

Authors:  Debanjan Mukhopadhyay; David Arranz-Solís; Jeroen P J Saeij
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.